Skip To Main Content
Melvin Sanicas on Muck Rack

Melvin Sanicas

Switzerland, Zürich
As seen in: LinkedIn, Medium, El País, HuffPost, BuzzFeed, TED, MarketWatch, Agenda (World Economic Forum), China Daily (English), Les Échos and
Covers:  viruses, bacteria, infectious diseases, vaccines, innovation, digital technologies, mental health, global health
Physician-scientist MD, MSc, MBA #FIDSA #FRSPH #FRSA #FAcadMEd #TOYM Science & Medicine '21 #PAFIOO #PresidentialAward '24 Sharing insights on #GlobalHealth

Get in touch with Melvin

Contact Melvin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Melvin Sanicas’s Biography

Read Full Bio →

Dr. Melvin Sanicas is a physician - scientist specializing in vaccines, infectious diseases, and global health. His op-eds and articles have appeared in The World Economic Forum Agenda, Project Syndicate, HuffPost, TED Ed, Forbes, El Pais, and in over 40 print & online publications worldwide. He is a Fellow of the Royal Society of Tropical Medicine and Hygiene, a Fellow of the Royal Society for Public Health, and a Fellow of the Royal Society of Arts.

Melvin Sanicas’s Journalist Portfolio

See all →
Extremely rare case of death from bat rabies in France

Extremely rare case of death from bat rabies in France

Most bats do not have rabies. According to the US Centers for Disease Control and Prevention (CDC), even amon…

View article →
New vaccine shows protection against aerosol tuberculosis infection in monkeys

New vaccine shows protection against aerosol tuberculosis infection in monkeys

The new tuberculosis vaccine MTBVAC takes a new step as a candidate for universal vaccination against tubercu…

View article →
COVID-19 antibodies last as long as 8 months

COVID-19 antibodies last as long as 8 months

Our current understanding of SARS-CoV-2 immunity is mainly based on previous experiences with SARS-CoV (2003)…

View article →
Can aspirin reduce the risk of death in hospitalized COVID-19 patients?

Can aspirin reduce the risk of death in hospitalized COVID-19 patients?

Researchers at the University of Maryland School of Medicine showed COVID-19 patients who were taking a daily…

View article →
FDA approves first Ebola treatment

FDA approves first Ebola treatment

Over 2 years since the Kivu Ebola epidemic began in August 2018, the US Food and Drug Administration (FDA) ap…

View article →
People with blood type O may face lower risk of coronavirus infection or have milder symptoms

People with blood type O may face lower risk of coronavirus infection or have milder symptoms

Two retrospective studies in Blood Advances add evidence for an association between blood type and COVID-19 r…

View article →

Articles

#malaria #chemoprevention | Melvin Sanicas

|
By Melvin Sanicas
| LinkedIn
A new Liverpool School of Tropical Medicine-led study found that providing #malaria #chemoprevention to children aged 5–15 years across 10 high-burden countries in sub-Saharan Africa could avert more than 9.1 million cases and over 20,000 deaths each year. ▪️ An annual investment of US$423 million was projected to generate US$5.7 billion in net societal benefits - equivalent to more than US$14 returned for every US$1 invested.
Open in Who Shared Issue with article?

#cancerresearch #sildenafil #viagra #metastasis #cancer #cholesterol #statins #cancerbiology #clinicaltrials

|
By Melvin Sanicas
| LinkedIn
A study published in #CancerResearch suggests that #sildenafil [#Viagra] may restrict #metastasis by disrupting #cancer cells’ access to #cholesterol - an essential component of cell membranes that supports their ability to detach, migrate and invade distant organs. ▫️ The research was led by Dr. Yarden Ariav in the laboratory of Professor Ayelet Erez at the Weizmann Institute of Science. The team found that sildenafil blocks PDE5, increasing levels of the signaling molecule cGMP.
Open in Who Shared Issue with article?

#colorectalcancer #gut #microbiome #mutations #gene #escherichiacoli #tumour #cancer #carcinoma #apc #polyps

|
By Melvin Sanicas
| LinkedIn
New research from the National Taiwan University College of Medicine suggests that #colorectalcancer development is shaped not only by genetic mutations, but also by changes in the #gut #microbiome. ▪️ Using mouse models, researchers found that #mutations in the adenomatous polyposis coli (APC) #gene disrupted the intestinal environment and promoted the emergence of invasive #Escherichiacoli E. coli.
Open in Who Shared Issue with article?
See all 231 licensed articles (232 Total)

Interview

See all →

Have you ever used a typewriter?

Yes. Typewriters don't need batteries, they never overheat, and your eyes won't hurt from staring too long at them.

What's your favorite social network?

Twitter, LinkedIn

Did you work for your high school newspaper? If so, what did you do there?

Yes, I was the Editor-in-Chief.